These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15265272)

  • 1. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?
    Aliyev A; Seyidova D; Rzayev N; Obrenovich ME; Lamb BT; Chen SG; Smith MA; Perry G; de la Torre JC; Aliev G
    Neurol Res; 2004 Jul; 26(5):547-53. PubMed ID: 15265272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease.
    Seyidova D; Aliyev A; Rzayev N; Obrenovich M; Lamb BT; Smith MA; de la Torre JC; Perry G; Aliev G
    In Vivo; 2004; 18(3):325-33. PubMed ID: 15341188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias.
    Togo T; Katsuse O; Iseki E
    Neurol Res; 2004 Jul; 26(5):563-6. PubMed ID: 15265275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease.
    Aliev G; Palacios HH; Lipsitt AE; Fischbach K; Lamb BT; Obrenovich ME; Morales L; Gasimov E; Bragin V
    Neurotox Res; 2009 Oct; 16(3):293-305. PubMed ID: 19526276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease.
    de la Monte SM; Sohn YK; Etienne D; Kraft J; Wands JR
    Ann N Y Acad Sci; 2000 Apr; 903():61-71. PubMed ID: 10818490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is non-genetic Alzheimer's disease a vascular disorder with neurodegenerative consequences?
    Aliev G
    J Alzheimers Dis; 2002 Dec; 4(6):513-6. PubMed ID: 12515902
    [No Abstract]   [Full Text] [Related]  

  • 7. AD brain pathology: vascular origins? Results from the HAAS autopsy study.
    Launer LJ; Petrovitch H; Ross GW; Markesbery W; White LR
    Neurobiol Aging; 2008 Oct; 29(10):1587-90. PubMed ID: 17466414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches.
    Zhu HY; Hong FF; Yang SL
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
    Brenner SR
    Neurology; 2008 Jan; 70(3):243-4. PubMed ID: 18195273
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular oxidative stress in Alzheimer disease.
    Zhu X; Smith MA; Honda K; Aliev G; Moreira PI; Nunomura A; Casadesus G; Harris PL; Siedlak SL; Perry G
    J Neurol Sci; 2007 Jun; 257(1-2):240-6. PubMed ID: 17337008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms.
    Pannu R; Singh I
    Neurochem Int; 2006 Jul; 49(2):170-82. PubMed ID: 16765486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular damage as a cause for Alzheimer's disease.
    Humpel C; Marksteiner J
    Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular inflammatory, oxidative and protease-based processes: implications for neuronal cell death in Alzheimer's disease.
    Christov A; Ottman JT; Grammas P
    Neurol Res; 2004 Jul; 26(5):540-6. PubMed ID: 15265271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
    de la Torre JC
    Neurol Res; 2004 Jul; 26(5):517-24. PubMed ID: 15265269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics.
    de la Torre JC
    Lancet Neurol; 2004 Mar; 3(3):184-90. PubMed ID: 14980533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
    Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
    Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease.
    Dorheim MA; Tracey WR; Pollock JS; Grammas P
    Biochem Biophys Res Commun; 1994 Nov; 205(1):659-65. PubMed ID: 7528015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease.
    Aliev G; Smith MA; Seyidov D; Neal ML; Lamb BT; Nunomura A; Gasimov EK; Vinters HV; Perry G; LaManna JC; Friedland RP
    Brain Pathol; 2002 Jan; 12(1):21-35. PubMed ID: 11770899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.
    de la Torre JC; Aliev G
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):663-72. PubMed ID: 15703700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.